Accepting PhD Students

PhD projects

<a href="" onclick="target='_blank';"></a>

1997 …2023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Patrick Kwan 

Department of Neuroscience research groups - Kwan Lab

Patrick Kwan is a clinician-researcher and an international authority in epileptology and antiepileptic drug development. He is a Professor of Neurology in the Department of Neuroscience within the Central Clinical School, and Co-Director of Monash Institute of Medical Engineering, a unique cross-faculty platform that supports research and promotes commercialisation of engineering solutions for unmet clinical needs.

In his clinical role, he is a Consultant Neurologist at Alfred Health with main clinical interest in epilepsy.

He is an elected Fellow of the Australian Academy of Health and Medical Sciences. He was previously Chair of Neurology at the Department of Medicine (Royal Melbourne Hospital), University of Medicine (2011-2017). He served as Chair of the Medical Therapies Commission of the International League Against from 2013 to 2017.

Professor Kwan’s research portfolio encompasses both applied basic science and clinical aspects to improve the treatment outcomes of epilepsy. His research goal is to realise personalised epilepsy management through understanding the long term outcomes, identifying factors that affect treatment response and mechanisms of drug resistance, and discovering novel molecular targets for the treatment and prevention of epilepsy. He has a particular interest in harnessing technologies to solve clinical problems. He supervises a highly multidisciplinary, integrated research team that spans across genomics, human stem cells, animal models, bioengineering, artificial intelligence, bio-databanks and clinical trials. He has extensive national and international collaborations in academia, hospitals and MedTech industry. 

He has published more than 340 peer-reviewed articles in leading journals including the New England Journal of Medicine, Lancet, British Medical Journal, Lancet Neurology, JAMA Neurology and Brain, that have been cited for more than 31,000 times. H-index 73. He ranks top 0.01% of more than 120,000 published authors worldwide on epilepsy. Twitter: @patrick_kwan

Research interests

1. Use of Artificial intelligence (AI) models in epilepsy including prediction of treatment outcomes, analysis of imaging, EEG, genomics, wearable data, and the ethical dilemmas (representative article:

2. Stem cell-derived neuronal platform for disease modelling and personalised drug discovery (

3. Biosensors for point-of-care molecular diagnosis and pharmacogenetic screening (;;

4. Next generation non-invasive wearables for seizure and health monitoring (

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 7 - Affordable and Clean Energy

Education/Academic qualification

Clinical Medicine, MB, BChir, University of Cambridge

Medicine and Therapeutics, PhD, University of Glasgow

Preclinical Medicine, BMedSci, University of Nottingham

External positions

Honorary Clinical Professor, University College London

1 Dec 202130 Nov 2026

Head of Epilepsy, Alfred Hospital

2 Oct 201730 Apr 2023

Research area keywords

  • Epilepsy
  • Point-of-care Diagnostics
  • Machine and Deep Learning Models
  • stem cell research
  • Genomics & Transcriptomics
  • Outcomes Research
  • Wearable Sensors

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or